SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-039291
Filing Date
2023-05-15
Accepted
2023-05-15 07:53:26
Documents
14
Period of Report
2023-05-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea178578-8k_biomxinc.htm   iXBRL 8-K 36961
2 PRESS RELEASE DATED MAY 15, 2023 ea178578ex99-1_biomxinc.htm EX-99.1 76882
  Complete submission text file 0001213900-23-039291.txt   357223

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE phge-20230511.xsd EX-101.SCH 4204
4 XBRL DEFINITION FILE phge-20230511_def.xml EX-101.DEF 27449
5 XBRL LABEL FILE phge-20230511_lab.xml EX-101.LAB 38219
6 XBRL PRESENTATION FILE phge-20230511_pre.xml EX-101.PRE 26069
8 EXTRACTED XBRL INSTANCE DOCUMENT ea178578-8k_biomxinc_htm.xml XML 7448
Mailing Address 22 EINSTEIN ST., 4TH FLOOR NESS ZIONA L3 7414003
Business Address 22 EINSTEIN ST., 4TH FLOOR NESS ZIONA L3 7414003 (972) 72 394 2377
BiomX Inc. (Filer) CIK: 0001739174 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38762 | Film No.: 23918454
SIC: 2836 Biological Products, (No Diagnostic Substances)